BRPI0518494A2 - adjuvante de emulsÕes de fléor carbono para terapia hifu e uso do mesmo - Google Patents

adjuvante de emulsÕes de fléor carbono para terapia hifu e uso do mesmo

Info

Publication number
BRPI0518494A2
BRPI0518494A2 BRPI0518494-0A BRPI0518494A BRPI0518494A2 BR PI0518494 A2 BRPI0518494 A2 BR PI0518494A2 BR PI0518494 A BRPI0518494 A BR PI0518494A BR PI0518494 A2 BRPI0518494 A2 BR PI0518494A2
Authority
BR
Brazil
Prior art keywords
hifu treatment
enhancement agent
fluoro
target location
core material
Prior art date
Application number
BRPI0518494-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Zhibiao Wang
Faqi Li
Liping Liu
Yanbing Xiao
Ziwen Xiao
Zhilong Wang
Original Assignee
Chongqing Haifu Hifu Tech Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Haifu Hifu Tech Co filed Critical Chongqing Haifu Hifu Tech Co
Publication of BRPI0518494A2 publication Critical patent/BRPI0518494A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0518494-0A 2005-01-10 2005-09-02 adjuvante de emulsÕes de fléor carbono para terapia hifu e uso do mesmo BRPI0518494A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510000343A CN100574809C (zh) 2005-01-10 2005-01-10 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
PCT/CN2005/001391 WO2006072200A1 (fr) 2005-01-10 2005-09-02 Adjuvant d’emulsions au fluorocarbure pour un traitement hifu et utilisation de celui-ci

Publications (1)

Publication Number Publication Date
BRPI0518494A2 true BRPI0518494A2 (pt) 2008-11-25

Family

ID=36647408

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518494-0A BRPI0518494A2 (pt) 2005-01-10 2005-09-02 adjuvante de emulsÕes de fléor carbono para terapia hifu e uso do mesmo

Country Status (13)

Country Link
US (1) US20080138290A1 (enExample)
EP (1) EP1839677B1 (enExample)
JP (1) JP2008526786A (enExample)
KR (1) KR20070094621A (enExample)
CN (1) CN100574809C (enExample)
AT (1) ATE491476T1 (enExample)
AU (1) AU2005324273B2 (enExample)
BR (1) BRPI0518494A2 (enExample)
CA (1) CA2593644C (enExample)
DE (1) DE602005025408D1 (enExample)
ES (1) ES2355038T3 (enExample)
RU (1) RU2388492C2 (enExample)
WO (1) WO2006072200A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948024B1 (fr) * 2009-07-17 2020-01-10 Centre National De La Recherche Scientifique - Cnrs - Emulsion activable par ultrasons et son procede de fabrication.
US8852103B2 (en) 2011-10-17 2014-10-07 Butterfly Network, Inc. Transmissive imaging and related apparatus and methods
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
CN103877598B (zh) * 2014-03-18 2016-04-27 苏晓婷 一种超声造影剂及其制备方法
CN105330786B (zh) * 2014-07-03 2017-07-14 重庆海扶医疗科技股份有限公司 一种治疗用超声耦合介质材料及其制备方法
CN105169420B (zh) * 2015-09-02 2018-01-05 上海市第十人民医院 一种新型射频诊疗剂及其制备方法
FR3082422B1 (fr) * 2018-06-14 2021-01-22 Univ D'avignon Et Des Pays De Vaucluse Emulsion pour la chirurgie d'ablation ultrasonore
CN117919402A (zh) * 2023-12-19 2024-04-26 中国科学院宁波材料技术与工程研究所 一种高强度聚焦超声用敏化剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832829A (ja) * 1981-08-22 1983-02-25 Green Cross Corp:The 血管造影剤
US4767610A (en) * 1984-10-19 1988-08-30 The Regents Of The University Of California Method for detecting abnormal cell masses in animals
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US6551576B1 (en) * 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6613306B1 (en) * 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
AU2076895A (en) * 1994-03-28 1995-10-17 Daiichi Pharmaceutical Co., Ltd. Liposomes
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US6165442A (en) * 1996-02-19 2000-12-26 Nycomed Imaging As Thermally stabilized ultrasound contrast agent
EA001135B1 (ru) * 1996-02-19 2000-10-30 Нюкомед Имагинг А/С Усовершенствования в области контрастных агентов
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6548047B1 (en) * 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
CN1194763C (zh) * 2002-09-06 2005-03-30 中国人民解放军第三军医大学 新型脂质体超声造影剂及其制备方法

Also Published As

Publication number Publication date
ATE491476T1 (de) 2011-01-15
EP1839677B1 (en) 2010-12-15
EP1839677A1 (en) 2007-10-03
RU2007127668A (ru) 2009-01-27
AU2005324273A1 (en) 2006-07-13
CA2593644A1 (en) 2006-07-13
RU2388492C2 (ru) 2010-05-10
JP2008526786A (ja) 2008-07-24
AU2005324273B2 (en) 2008-08-14
EP1839677A4 (en) 2008-03-19
ES2355038T3 (es) 2011-03-22
CN1803196A (zh) 2006-07-19
KR20070094621A (ko) 2007-09-20
WO2006072200A1 (fr) 2006-07-13
CA2593644C (en) 2011-06-07
CN100574809C (zh) 2009-12-30
US20080138290A1 (en) 2008-06-12
DE602005025408D1 (de) 2011-01-27

Similar Documents

Publication Publication Date Title
Ter Haar Therapeutic applications of ultrasound
WO2007014323A3 (en) Use of heat shock to treat ocular disease
BRPI0518494A2 (pt) adjuvante de emulsÕes de fléor carbono para terapia hifu e uso do mesmo
CO2018011356A2 (es) Sistemas y metodos para el tratamiento cosmético de ultrasonido de la piel
LTPA2017011I1 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
DE60134177D1 (de) Eingriffsfreie ultraschall körperkonturierung
WO2007127390A3 (en) Materials and methods for wound treatment
DE602006009072D1 (de) Gerät zur bereitstellung eines wärmenden oder kühlenden effekts
BRPI0815009A2 (pt) (2s,3r)-n-(2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il) benzofuran-2-carboxamida, novas formas de sal, e métodos de uso do mesmo.
FI1897548T4 (fi) T-solujen säätely
JP2008503275A5 (enExample)
WO2006023537A3 (en) Solid statae pump
DE502006007971D1 (de) Wässrige monomeremulsionen enthaltend hydrophobin
BRPI0518497A2 (pt) adjuvante particulado para terapia hifu e uso do mesmo
WO2012068014A3 (en) Treatment of nail disease
BRPI0613752A2 (pt) agente fungicidamente ativo, kit de 2- componentes, processo para combater fungos nocivos, e, uso do agente
NO20041024D0 (no) Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene
WO2006004716A3 (en) Amelioration of drug-induced toxicity
EP1580002A3 (en) Fluid supply having a fluid absorbing material cross-reference to related application
WO2008038193A3 (en) Feedback loop for focused ultrasound application
ATE548242T1 (de) Energie absorbierende vorrichtung
JP2008519845A5 (enExample)
ITTO20050330A1 (it) Dispositivo trasduttore fluidodinamico per lo sfruttamento dell'energia cinetica di veicoli terrestri.
BRPI0500336A (pt) processo de preparação de uma composição para o tratamento cosmético das matérias queratìnicas, composição de tratamento cosmético, processos de tratamento cosmético das matérias queratìnicas, uso de uma composição e dispositivo de condicionamento de um composto
JP2005538281A5 (enExample)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.